These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
234 related articles for article (PubMed ID: 19121065)
1. Multiple components contribute to ability of saliva to inhibit influenza viruses. White MR; Helmerhorst EJ; Ligtenberg A; Karpel M; Tecle T; Siqueira WL; Oppenheim FG; Hartshorn KL Oral Microbiol Immunol; 2009 Feb; 24(1):18-24. PubMed ID: 19121065 [TBL] [Abstract][Full Text] [Related]
2. Comparison of proteins with anti-influenza virus effects in parotid and submandibular-sublingual saliva in humans. Yamamoto K; Yamamoto S BMC Oral Health; 2022 Dec; 22(1):639. PubMed ID: 36566172 [TBL] [Abstract][Full Text] [Related]
3. Salivary agglutinin and lung scavenger receptor cysteine-rich glycoprotein 340 have broad anti-influenza activities and interactions with surfactant protein D that vary according to donor source and sialylation. Hartshorn KL; Ligtenberg A; White MR; Van Eijk M; Hartshorn M; Pemberton L; Holmskov U; Crouch E Biochem J; 2006 Jan; 393(Pt 2):545-53. PubMed ID: 16190864 [TBL] [Abstract][Full Text] [Related]
4. Cooperative anti-influenza activities of respiratory innate immune proteins and neuraminidase inhibitor. White MR; Crouch E; van Eijk M; Hartshorn M; Pemberton L; Tornoe I; Holmskov U; Hartshorn KL Am J Physiol Lung Cell Mol Physiol; 2005 May; 288(5):L831-40. PubMed ID: 15608147 [TBL] [Abstract][Full Text] [Related]
5. Innate defense against influenza A virus: activity of human neutrophil defensins and interactions of defensins with surfactant protein D. Hartshorn KL; White MR; Tecle T; Holmskov U; Crouch EC J Immunol; 2006 Jun; 176(11):6962-72. PubMed ID: 16709857 [TBL] [Abstract][Full Text] [Related]
6. Inhibition of HIV-1 IIIB and clinical isolates by human parotid, submandibular, sublingual and palatine saliva. Bolscher JG; Nazmi K; Ran LJ; van Engelenburg FA; Schuitemaker H; Veerman EC; Nieuw Amerongen AV Eur J Oral Sci; 2002 Apr; 110(2):149-56. PubMed ID: 12013559 [TBL] [Abstract][Full Text] [Related]
7. Lung and salivary scavenger receptor glycoprotein-340 contribute to the host defense against influenza A viruses. Hartshorn KL; White MR; Mogues T; Ligtenberg T; Crouch E; Holmskov U Am J Physiol Lung Cell Mol Physiol; 2003 Nov; 285(5):L1066-76. PubMed ID: 12871854 [TBL] [Abstract][Full Text] [Related]
8. Identification of histatins as tannin-binding proteins in human saliva. Yan Q; Bennick A Biochem J; 1995 Oct; 311 ( Pt 1)(Pt 1):341-7. PubMed ID: 7575474 [TBL] [Abstract][Full Text] [Related]
9. Histatins enhance wound closure with oral and non-oral cells. Oudhoff MJ; van den Keijbus PA; Kroeze KL; Nazmi K; Gibbs S; Bolscher JG; Veerman EC J Dent Res; 2009 Sep; 88(9):846-50. PubMed ID: 19767583 [TBL] [Abstract][Full Text] [Related]
10. Serum amyloid P is a sialylated glycoprotein inhibitor of influenza A viruses. Job ER; Bottazzi B; Gilbertson B; Edenborough KM; Brown LE; Mantovani A; Brooks AG; Reading PC PLoS One; 2013; 8(3):e59623. PubMed ID: 23544079 [TBL] [Abstract][Full Text] [Related]
11. Aggregation of human immunodeficiency virus type 1 by human salivary secretions. Bergey EJ; Cho MI; Hammarskjöld ML; Rekosh D; Levine MJ; Blumberg BM; Epstein LG Crit Rev Oral Biol Med; 1993; 4(3-4):467-74. PubMed ID: 8373999 [TBL] [Abstract][Full Text] [Related]
12. The comparative inhibitory potency of salivary mucins against human immunodeficiency virus type 1. McQuaid IK; Dorfman JR; Mall AS Virology; 2021 Jan; 553():1-8. PubMed ID: 33190061 [TBL] [Abstract][Full Text] [Related]
13. Human H-ficolin inhibits replication of seasonal and pandemic influenza A viruses. Verma A; White M; Vathipadiekal V; Tripathi S; Mbianda J; Ieong M; Qi L; Taubenberger JK; Takahashi K; Jensenius JC; Thiel S; Hartshorn KL J Immunol; 2012 Sep; 189(5):2478-87. PubMed ID: 22851708 [TBL] [Abstract][Full Text] [Related]
14. Reduced influenza viral neutralizing activity of natural human trimers of surfactant protein D. Hartshorn KL; White MR; Tecle T; Tornoe I; Sorensen GL; Crouch EC; Holmskov U Respir Res; 2007 Feb; 8(1):9. PubMed ID: 17280604 [TBL] [Abstract][Full Text] [Related]
15. Inhibition of influenza viral neuraminidase activity by collectins. Tecle T; White MR; Crouch EC; Hartshorn KL Arch Virol; 2007; 152(9):1731-42. PubMed ID: 17514488 [TBL] [Abstract][Full Text] [Related]
16. The human cathelicidin LL-37 inhibits influenza A viruses through a mechanism distinct from that of surfactant protein D or defensins. Tripathi S; Tecle T; Verma A; Crouch E; White M; Hartshorn KL J Gen Virol; 2013 Jan; 94(Pt 1):40-49. PubMed ID: 23052388 [TBL] [Abstract][Full Text] [Related]
17. Influenza A viruses of swine circulating in the United States during 2009-2014 are susceptible to neuraminidase inhibitors but show lineage-dependent resistance to adamantanes. Baranovich T; Bahl J; Marathe BM; Culhane M; Stigger-Rosser E; Darnell D; Kaplan BS; Lowe JF; Webby RJ; Govorkova EA Antiviral Res; 2015 May; 117():10-9. PubMed ID: 25701593 [TBL] [Abstract][Full Text] [Related]
18. Effect of donor age on the concentrations of histatins in human parotid and submandibular/sublingual saliva. Johnson DA; Yeh CK; Dodds MW Arch Oral Biol; 2000 Sep; 45(9):731-40. PubMed ID: 10869486 [TBL] [Abstract][Full Text] [Related]
19. Proteases essential for human influenza virus entry into cells and their inhibitors as potential therapeutic agents. Kido H; Okumura Y; Yamada H; Le TQ; Yano M Curr Pharm Des; 2007; 13(4):405-14. PubMed ID: 17311557 [TBL] [Abstract][Full Text] [Related]
20. Adsorption of human salivary proteins to hydroxyapatite: a comparison between whole saliva and glandular salivary secretions. Jensen JL; Lamkin MS; Oppenheim FG J Dent Res; 1992 Sep; 71(9):1569-76. PubMed ID: 1381733 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]